CAI
Caris Life Sciences
186 hedge funds and large institutions have $3.92B invested in Caris Life Sciences in 2025 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 64 increasing their positions, 30 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
35% more funds holding
Funds holding: 138 → 186 (+48)
15% more capital invested
Capital invested by funds: $3.41B → $3.92B (+$506M)
11.18% more ownership
Funds ownership: 40.33% → 51.5% (+11%)
Holders
186
Holding in Top 10
7
Calls
$14.4M
Puts
$5.09M
Top Buyers
| 1 | +$129M | |
| 2 | +$87.7M | |
| 3 | +$79.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$54.9M |
| 5 |
BlackRock
New York
|
+$48.6M |
Top Sellers
| 1 | -$160M | |
| 2 | -$141M | |
| 3 | -$59.1M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$33.3M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$33.3M |
